New hope for the treatment of neurodegenerative diseases including Lewy bodies dementia and Parkinson’s disease

A new research published in Neuropathology and Applied Neurobiology, has established that Toxic proteins within the brain that cause Parkinson’s disease and Lewy body dementia have the potential to help develop new targeted therapies.

Research into modified RNA messages could help treat diseases and develop new therapies

University of Nottingham experts – led by Dr Helen Miranda Knight – have discovered that the modification of ribonucleic acid (RNA) in human brain tissue is disrupted among neurodegenerative diseases. These conditions include Lewy bodies dementia and Parkinson’s disease.

You can read the full article here:

https://onlinelibrary.wiley.com/action/doSearch?AllField=modified+m6a&SeriesKey=13652990